NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...
Discover how medical 3D printing creates patient-specific devices and custom prosthetics. Read our guide to clinical ...
Background The use of artificial chords for mitral valve prolapse during minimally invasive mitral valve repair (MIMVR) has ...
Explore how medical robots and healthcare robotics enhance surgery, diagnostics, and hospital workflows, highlighting key ...
An analysis has found that anti-amyloid drugs, once hailed as a breakthrough in Alzheimer's treatment, have low clinical ...
Peer-reviewed study confirming strong predictive performance of patient-specific lung digital twins, validated against ...
Bringing a single drug to market can take more than a decade and cost billions of dollars, with fewer than one in ten candidates successfully reaching approval. Against this backdrop, generative AI is ...
Ebenbuild GmbH, a Munich-based deep-tech healthcare company, today announced the publication of a peer-reviewed ...
Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...
Objective: To address this gap, we conducted a pre-registered meta-analysis to synthesize findings from rigorously designed randomized controlled trials (i.e., low attrition, comparable baseline ...
Natural product libraries enable the discovery of bioactive compounds through diverse screening workflows. Inherent ...
Abstract: To address the core issue of high-dimensional data processing in hyperspectral pathological diagnosis, we develop a new feature selection framework using functional data analysis (FSFDA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results